Results 121 to 130 of about 8,132 (145)

Next-generation macrophage engineering in cancer therapy: From TAM reprogramming to CAR-macrophages. [PDF]

Mol Ther Nucleic Acids
Nilova O, Zajakina A.
europepmc   +1 more source

Distinct thymic pDC populations promote tumor immune tolerance through complementary mechanisms. [PDF]

Sci Adv
Wang Y, Koyama-Nasu R, Endo Y, Hasegawa I, Onodera A, Chen M, Hirahara K, Motohashi S, Nakayama T, Kimura MY.   +9 more
europepmc   +1 more source

Targeting the CD47/SIRPα interaction in cancer: opportunities in non-Hodgkin lymphoma. [PDF]

Expert Opin Investig Drugs
Pagès-Geli C, Weiskopf K.
europepmc   +1 more source

Therapeutic monoclonal antibodies for diabetic kidney disease: a narrative review from basic mechanisms to clinical evidence. [PDF]

Front Endocrinol (Lausanne)
Yang XH, Liu Y, Fu CS, Jin HM, Ye ZB.
europepmc   +1 more source

3D-printed implantable CAR-macrophages for post-surgery cancer immunotherapy. [PDF]

J Nanobiotechnology
Nie D, Shen Y, Xu Y, Hu X, Qiu J, Hu X, Meng QF, She P, Rao L, Huang Q.   +9 more
europepmc   +1 more source

Myeloid cell-mediated killing of B-ALL by CD38 and CD20 IgA antibody variants is enhanced by CD47/SIRPα interference. [PDF]

Blood Neoplasia
Lustig M, Kowol M, Hartmann AM, van der Peet IC, Jansen MJH, Iben K, Winterberg D, Krohn S, Baumann N, Rösner T, Bendig S, Hahn C, Wurm AA, Gehlert CL, Denker M, Suwanchaikasem P, Macarrón Palacios A, Schwartz S, Brüggemann M, Burger R, Schmitt K, Klausz K, Valerius O, Stölzel F, Bastian L, Baldus CD, Peipp M, Leusen JHW, Schewe DM, Valerius T.   +29 more
europepmc   +1 more source

Immune escape in endometriosis: mechanisms, reprogramming strategies, and precision interventions. [PDF]

Reprod Biol Endocrinol
Chen H, Zhang M, Fei W, Zhang Q, Peng Y, Zhu L, Ding S, Zhang X, Chen Z, Zhao M.   +9 more
europepmc   +1 more source

The SIRP family: from structural diversity and signaling mechanisms to implications in immune-related disease targeted therapeutics. [PDF]

Front Immunol
Jin Y, Huang Q, Song J, Abideen ZU, Tan R, Xu S, Chen M.   +6 more
europepmc   +1 more source

Editorial: Emerging mechanisms in neuroinflammation: potential therapeutic targets for neurodegenerative diseases. [PDF]

Front Cell Neurosci
Wang J, Wang H, Hermann DM.
europepmc   +1 more source

Advances in Immune Checkpoint Inhibitors for Cancer Treatment. [PDF]

Cancers (Basel)
Chen K, Zhu F, Li X, Yoshimura T.
europepmc   +1 more source